Private company

Pharmstandard

Logo: Pharmstandard, Public domain, via Wikimedia Commons3

Russian pharmaceutical company

JSC Pharmstandard (Russian: ПАО "Фармстандарт", romanized: PAO "Farmstandart") is a Russian multinational pharmaceutical company. It is headquartered in Dolgoprudny, Moscow Oblast. Pharmstandard's makes and exports over 400 generic and proprietary drugs, including products used in the treatment of diabetes, growth hormone deficiency, cardiovascular diseases, gastroenterological and neurological disorders, infectious diseases, cancer, etc.2 It employed 6,450 people in 2015.1 Its revenue was ₽37.2 billion in 2017.1 Wikipedia text CC BY-SA 4.0

Last updated Oct 21, 2026.

Overview

2003Founded1
  • HeadquartersDolgoprudny1
  • Websitewww.phstd.ru
  • Legal formjoint-stock company1
  • Listed onMoscow Exchange1

JSC Pharmstandard (Russian: ПАО "Фармстандарт", romanized: PAO "Farmstandart") is a Russian multinational pharmaceutical company. It is headquartered in Dolgoprudny, Moscow Oblast.2

The story

Pharmstandard was established in 2003 as a result of a merger.

In May 2007 the company raised $880 million in an IPO, valuing the company at $2.2 billion. Roman Abramovich owned a 17% stake in the company until March 2008.

In 2013 the company announced plans to buy the ingredient supplier Bever Pharmaceutical, causing Pharmstandard shares to fall 25%.

Pharmstandard was delisted from the London and Moscow stock exchanges in 2017.

From Wikipedia’s article on Pharmstandard, shared under CC BY-SA 4.0.4

Employees over time

  • 20156,4501

Revenue over time

As stated on Wikidata, in the currency reported.

Revenue

Pharmstandard revenue by year137.2B RUB in 2017−40% since 2016
020.0B RUB40.0B RUB60.0B RUB80.0B RUB2016: 61.8B RUB61.8B RUB20162017: 37.2B RUB37.2B RUB2017−40%
  • 201737.2B RUB1
  • 201661.8B RUB1

Net income

  • 20168.0B RUB1

Timeline

  1. 2003Founded Founded1

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4